Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Symeres acquires US organic chemistry firm Organix

by Michael McCoy
April 30, 2022 | A version of this story appeared in Volume 100, Issue 15

 

A person working in a chemistry lab.
Credit: Organix
Organix operates labs in Woburn, Massachusetts.

Symeres, a Dutch contract research organization (CRO) serving the drug industry, has acquired Organix, a Massachusetts-based organic chemistry CRO with a focus on lipids. Symeres says Organix has annual sales of over $10 million and about 45 employees, most of whom are PhD chemists. Symeres says the purchase will take its annual sales to about $95 million and provide its first outpost in the US, where it generates close to half its revenues.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.